NSPR - צמיחת הכנסות ב-12 חודשים נגררים InspireMD Inc.

InspireMD, Inc. (NSPR) automates the production of vascular stents through robotic braiding and laser processing, eliminating manual labor. The current 12-month trailing revenue dynamics illustrate this process, where 35.60 serves as the final level marker. MicroNet technologies in Germany and Israel ensure quality, while expansion in the US through surgeon training defines the growth trajectory.
inspiremd.com (NSPR) - פילוחי מדדים ודוחות פיננסיים

The market value of the asset is based on the discounting of future cash flows. A 12-month calculation neutralizes seasonality and one-time distortions, revealing the true growth trajectory of the business. Analyzing the rolling annual sales growth rate allows for the timely detection of a fundamental decline. For InspireMD, Inc. (NSPR), this trend is confirmed by the high barrier to entry in the micro-mesh stent sector. Patent protection and regulatory approvals create a sustainable moat against competitors.